Log in to save to my catalogue

Hematopoietic SCT in Europe: data and trends in 2011

Hematopoietic SCT in Europe: data and trends in 2011

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3763517

Hematopoietic SCT in Europe: data and trends in 2011

About this item

Full title

Hematopoietic SCT in Europe: data and trends in 2011

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1161-1167

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

In all, 651 from 680 centers in 48 countries reported 35 660 hematopoietic SCT (HSCT) in 32 075 patients (13 470 allogeneic (42%), 18 605 autologous (58%)) to the 2011 survey. Main indications were: leukemias; 10 113 (32%; 94% allogeneic); lymphoid neoplasias; non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, plasma cell disorders; 18 433 (57%; 12% allog...

Alternative Titles

Full title

Hematopoietic SCT in Europe: data and trends in 2011

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3763517

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3763517

Other Identifiers

ISSN

0268-3369,1476-5365

E-ISSN

1476-5365

DOI

10.1038/bmt.2013.51

How to access this item